Genetically engineered mice have become an essential tool in biomedical research. They are crucial tools for
studying development of the skin and its appendages. In addition, these mouse models have become
indispensible for creating models of human skin disorders, including inherited and aquired skin disorders and
skin cancer. Generating transgenic or knockout mice requires specialized skills and expensive equipment.
Consequently, very few laboratories have the ability to generate these valuable research models. The Transgenic
and Gene Targeting (TGT) Core at the University of Colorado Denver offers a comprehensive set of services
which enables investigators to generate genetically engineered mice. These services include the generation of
transgenic mice via pronuclear injections, and gene targeting experiments that include the entire process from
generating recombinant ES cells to the production of chimeric mice. All that is required from the investigators to
initiate these experiments is a transgenic vector or gene targeting vector. Furthermore, our core offers extensive
consultation services to help investigators with the development of a research plan, including vector design,
animal design, and the analysis of genetically engineered mice. 23 investigators of the Skin Disease Research
Core Center (UCD-SDRC) are planning to use our core services to generate mouse models to study skin biology
or skin diseases. Core Center support for our core will provide these investigators with subsidized access to the
full set of our services, and thus facilitate their research.
Public Health Relevance Statement
The services of the proposed core component (Transgenic and Gene Targeting Core) are essential for the
ability of Core Center investigators to generate animal models for skin diseases. Funds provided to the
Transgenic and Gene Targeting Core will provide access of Core Center members to subsidized core
services such as pronuclear injections to generate transgenic mice and ES cell injections to generate
"knockout" and "knockin" mice.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
CFDA Code
DUNS Number
041096314
UEI
MW8JHK6ZYEX8
Project Start Date
28-September-2009
Project End Date
30-June-2014
Budget Start Date
28-September-2009
Budget End Date
30-June-2010
Project Funding Information for 2009
Total Funding
$146,784
Direct Costs
$95,625
Indirect Costs
$51,159
Year
Funding IC
FY Total Cost by IC
2009
National Institute of Arthritis and Musculoskeletal and Skin Diseases
$146,784
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1P30AR057212-01 6386
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1P30AR057212-01 6386
Patents
No Patents information available for 1P30AR057212-01 6386
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1P30AR057212-01 6386
Clinical Studies
No Clinical Studies information available for 1P30AR057212-01 6386
News and More
Related News Releases
No news release information available for 1P30AR057212-01 6386
History
No Historical information available for 1P30AR057212-01 6386
Similar Projects
No Similar Projects information available for 1P30AR057212-01 6386